PERFUSION SYSTEMS CARDIOBLATE ABLATION PEN; SURGICAL DEVICE, FOR CUTTING, COAGULATION, AND/OR ABLATION OF TISSUE, INCLUDING
|
Back to Search Results |
|
Model Number 60813 |
Device Problem
High impedance (1291)
|
Patient Problem
Burn(s) (1757)
|
Event Date 02/17/2022 |
Event Type
Injury
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Medtronic received information that during use of a cardioblate probe, the customer reported that during the ablation of the left atrium, the first three ablation lines were successfully completed.However, during the operation of the fourth line, it was found that the contacted tissue was eschar.The customer checked that there was no water at the tip of the unipolar pen, checked that the pressure bag was normal, and the pipeline was arranged, but there was still no water.The customer stated that the eschar tissue might have been caused by the temperature of the single-stage pen tip being too high, and that there was no water.The patient did not require any additional treatment or intervention due to the eschar tissue.The device was replaced to complete the procedure.There was no patient impact associated with this event.Additional information reported that the device had not been connected 6 hours prior to the use, it took about 20 minutes to connect.It was asked but unknown whether there was an error code listed on the generator, and whether there was a low impedance error.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|